Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction
Status:
Recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
The main objective is to evaluate the efficacy of two intensified consolidation strategies in
very-high risk neuroblastoma (VHR-NBL) patients in terms of event-free survival from
randomisation date. This evaluation will follow a hierarchical testing procedure: each
experimental treatment will be first evaluated as a single-arm phase 2 study, and in case of
positive conclusion, the relative efficacy of both arms will then be evaluated comparatively.
Phase:
Phase 2
Details
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Collaborators:
French National Cancer Institute National Cancer Institute, France SIOPEN